Tanzania Lung Cancer Therapeutics Market Analysis

Tanzania Lung Cancer Therapeutics Market Analysis

$ 3999

By 2030, it is anticipated that the Tanzania Lung Cancer Therapeutics Market will reach a value of $24 Mn from $12 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The Lung Cancer Therapeutics Market in Tanzania is dominated by a few domestic pharmaceutical companies such as Dawa Limited, Africure Pharmaceuticals Limited, and Incepta Pharmaceuticals. The Lung Cancer Therapeutics Market in Tanzania is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Tanzania lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.

ID: IN10TZPH041 CATEGORY: Pharmaceuticals GEOGRAPHY: Tanzania AUTHOR: Dr. Vishwa Modhia

Buy Now

Tanzania Lung Cancer Therapeutics Analysis Summary

By 2030, it is anticipated that the Tanzania Lung Cancer Therapeutics market will reach a value of $24 Mn from $12 Mn in 2022, growing at a CAGR of 9% during 2022-30.

Tanzania is a low-income, developing country in East Africa bordering the Indian Ocean. In 2018, the age-standardized rate per 100,000 people for all ages was 0.9 for males and 0.2 for females. Cancer is Tanzania's biggest noncommunicable disease, followed by diabetes and cardiovascular disease. Tanzania has seen a steady and large increase in cancer cases. According to the International Agency for Research on Cancer (IARC), 42,060 new instances of cancer are identified in Tanzania each year, with a high mortality rate of 28,610 deaths per year, indicating that many patients are detected at advanced stages.

According to the latest WHO data published in 2020 Lung cancer deaths in Tanzania reached 159 or 0.05% of total deaths. The age-adjusted Death Rate is 0.60 per 100,000 population ranks Tanzania 181st in the world. Tanzania's government spends 3.8% of its GDP on healthcare.

Tanzania Lung Cancer Therapeutics Analysis

Market Dynamics

Market Growth Drivers

In Tanzania, 19.8 % of men and 2.2 % of women smoke daily. In 2017, Tanzania had 96 % of its people utilising solid fuels, which causes lung cancer. Aga Khan Hospital Dar es Salaam, Bugando Medical Centre, Kilimanjaro Christian Medical Centre, and the Ocean Road Cancer Institute are also major cancer centres. Tanzania is developing a regional cooperation strategy. In addition, the country receives international assistance in the form of concessional loans. These aspects could boost Tanzania's Lung Cancer Therapeutics market.

Market Restraints

A cancer diagnosis is upsetting anywhere in the world, but in Tanzania, it is frequently a death sentence. Because 80 % of cases are discovered at an advanced stage, supportive treatment and symptom control are frequently all that can be provided. Tanzania has very few cancer treatment centres. Furthermore, not all patients can travel significant distances to obtain therapy. Many people would rather not be treated at all. The route to acquire treatment, the financial burden, the availability of cancer facilities, the availability of chemotherapy and radiation therapy, the lack of information, and the stigma associated with cancer in Tanzania are all factors that contribute to people not seeking medical attention. These factors may deter new entrants into the Tanzania Lung Cancer Therapeutics market.

Competitive Landscape

Key Players

  • Dawa Limited: Dawa Limited is a Tanzanian pharmaceutical company that specializes in the production and distribution of generic medicines. The company offers a range of lung cancer treatments including chemotherapy drugs
  • Africure Pharmaceuticals Limited: Africure Pharmaceuticals Limited is a Tanzanian pharmaceutical company that specializes in the production and distribution of pharmaceutical products. The company offers a range of lung cancer treatments including chemotherapy drugs
  • Incepta Pharmaceuticals Tanzania Limited: Incepta Pharmaceuticals Tanzania Limited is a subsidiary of Incepta Pharmaceuticals, a Bangladeshi pharmaceutical company. The company offers a range of lung cancer treatments including chemotherapy drugs
  • Medisel Tanzania Limited: Medisel Tanzania Limited is a Tanzanian pharmaceutical company that specializes in the distribution of pharmaceutical products. The company offers a range of lung cancer treatments including chemotherapy drugs
  • Quality Chemicals Tanzania Limited: Quality Chemicals Tanzania Limited is a Tanzanian pharmaceutical company that specializes in the production and distribution of pharmaceutical products. The company offers a range of lung cancer treatments including chemotherapy drugs

Healthcare Policies and Reimbursement Scenarios

The Tanzania Food and Drugs Authority (TFDA) is the regulatory authority in Tanzania responsible for the approval and regulation of therapeutic items, including lung cancer therapies. The TMDA is now in charge of regulating the quality, safety, and efficacy of medicines, medical equipment, diagnostics, biocides, and tobacco products. Most Tanzanians lack insurance and are impoverished. While not all cancer centres provide free care, there is still a long waiting list for cancer treatment, especially considering the scarcity of institutions equipped with the necessary diagnostic and therapeutic technology. A person with cancer may have to wait months after being diagnosed to begin treatment at a public institution.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Lung Cancer Therapeutics Segmentation

By Type (Revenue, USD Billion):

  • Small Cell Lung Cancer
  • Non-small Cell Lung Cancer
  • Lung Carcinoid Tumor

By Therapy (Revenue, USD Billion):

  • Radiation Therapy
  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy
  • Others

By Type of Molecule (Revenue, USD Billion):

  • Small Molecules
  • Biologics

By Drug Class (Revenue, USD Billion):

  • Alkylating Agents
  • Antimetabolites
  • Multikinase Inhibitors
  • Mitotic Inhibitors
  • EGFR Inhibitors
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 08 February 2024
Updated by: Riya Doshi

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter